Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Zai Lab (ZLAB) Shares Outstanding (Diluted Average) (2018 - 2025)

Historic Shares Outstanding (Diluted Average) for Zai Lab (ZLAB) over the last 6 years, with Q3 2025 value amounting to $1.1 billion.

  • Zai Lab's Shares Outstanding (Diluted Average) rose 1226.31% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 1226.31%. This contributed to the annual value of $989.5 million for FY2024, which is 238.86% up from last year.
  • Zai Lab's Shares Outstanding (Diluted Average) amounted to $1.1 billion in Q3 2025, which was up 1226.31% from $1.1 billion recorded in Q2 2025.
  • Zai Lab's 5-year Shares Outstanding (Diluted Average) high stood at $1.1 billion for Q3 2025, and its period low was $929.9 million during Q4 2021.
  • For the 5-year period, Zai Lab's Shares Outstanding (Diluted Average) averaged around $983.2 million, with its median value being $965.6 million (2023).
  • In the last 5 years, Zai Lab's Shares Outstanding (Diluted Average) soared by 1973.07% in 2021 and then soared by 62.23% in 2023.
  • Quarter analysis of 5 years shows Zai Lab's Shares Outstanding (Diluted Average) stood at $929.9 million in 2021, then grew by 3.03% to $958.1 million in 2022, then rose by 0.87% to $966.4 million in 2023, then increased by 2.39% to $989.5 million in 2024, then grew by 11.38% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.